{"id":"W2955917209","doi":"10.1016/j.jcf.2019.06.009","title":"A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis","year":2019,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Children's Hospital; SickKids Foundation; Hospital for Sick Children","funders":"Vertex Pharmaceuticals; Gilead Sciences; Cystic Fibrosis Foundation","keywords":"Ivacaftor; Medicine; Tolerability; Cystic fibrosis; Adverse effect; Internal medicine; Cystic fibrosis transmembrane conductance regulator","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001468278,0.0012095,0.001693241,0.0004022328,0.0005170435,0.0008747819,0.0007074981,0.001150103,0.002508789],"category_scores_gemma":[0.0008203033,0.0005292363,0.001375167,0.0002801714,0.0006126208,0.0005864548,0.0003752075,0.003000558,0.0005481035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008710095,"about_ca_system_score_gemma":0.002502925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002650961,"about_ca_topic_score_gemma":0.006038657,"domain_scores_codex":[0.9993399,0.000282113,0.00003301947,0.0001164182,0.00007933168,0.0001492636],"domain_scores_gemma":[0.9990976,0.0001108868,0.0001653108,0.00004538319,0.00009384819,0.0004869521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5988852,0.1471825,0.03633896,0.0009580819,0.002222343,0.001528803,0.000744856,0.003386348,0.07955958,0.0003864703,0.006060643,0.1227461],"study_design_scores_gemma":[0.3625422,0.5859364,0.03898199,0.00005835083,0.0004223556,0.000822859,0.0001355552,0.0008760747,0.005315157,0.0001211442,0.00474967,0.00003823268],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932834,0.001408606,0.0004177862,0.0002980905,0.00009323106,0.002575161,0.001003956,0.00006714612,0.0008526322],"genre_scores_gemma":[0.9877107,0.001729051,0.002445109,0.0008940653,0.0001175547,0.002891591,0.002035558,0.00003736102,0.002139007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002650961,"threshold_uncertainty_score":0.008392751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01046764723552414,"score_gpt":0.2987505867741172,"score_spread":0.2882829395385931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}